Keyphrases
APOE4
100%
Alzheimer's Disease
69%
Torpedo
62%
Apolipoprotein E Knockout Mice
41%
Apolipoprotein E
32%
Synaptosomes
26%
Acetylcholine Release
26%
Cholinergic Neurons
24%
Acetylcholine
24%
ApoE3
23%
Synaptic Vesicle
22%
Pathological Effect
20%
Nerve Terminal
19%
Electric Organ
17%
Transgenic Mice
16%
Hippocampus
16%
Amyloid Cascade
15%
Closed Head Injury
15%
ApoE
14%
Genetic Risk
13%
Neurofilament
13%
NF-H
13%
Cognitive Deficits
11%
Apolipoprotein E-deficient
11%
Neurodegeneration
11%
Phosphorylation
10%
Ca2+
10%
Neurofilament Protein
10%
Targeted Replacement Mice
10%
Apolipoprotein E3
9%
Immunization
9%
Muscarinic Agonists
8%
Experimental Autoimmune
8%
Autoimmune Dementia
8%
Environmental Stimulation
8%
Alzheimer's Disease Patient
8%
Cholinergic Nerves
8%
Derangement
7%
Electromotor
7%
Phospholipids
7%
Synaptic
7%
ATP-binding Cassette Transporter A1 (ABCA1)
7%
APOE Genotype
7%
Brain Regions
7%
Muscarinic Acetylcholine Receptor
7%
Astrocytes
7%
Mouse Model
7%
Presynaptic muscarinic Receptors
6%
Amyloid Precursor Protein
6%
Muscarinic Receptors
6%
Neuroscience
Alzheimer's Disease
76%
Cholinergic
63%
Apolipoprotein E4
60%
Apolipoprotein E
54%
In Vivo
26%
Acetylcholine Release
25%
Amyloid
24%
Synaptosome
23%
Acetylcholine
20%
Hippocampus
19%
Cognitive Disorders
18%
Neurofilament
17%
Muscarinic Acetylcholine Receptor
16%
Closed Head Injury
15%
Synaptic Vesicle
13%
Agonist
12%
Astrocyte
10%
Neurofilament Protein
9%
Apolipoprotein E3
9%
Neurodegeneration
9%
Metabolic Pathway
9%
Eicosanoid Receptor
9%
Neprilysin
8%
Muscarinic Agonist
8%
Hyperphosphorylation
7%
Vascular Endothelial Growth Factor
7%
Brain Areas
7%
Epitope
6%
Acetylcholinesterase
6%
Amyloid Precursor Protein
6%
Phospholipid
6%
In Vitro
6%
Opiate
6%
Synaptophysin
5%
Acetylcholinesterase Inhibitor
5%
Learning Disabilities
5%
Morphine
5%
Monoclonal Antibody
5%
Adenosine Triphosphate
5%